Since the lesions of our patient shrank dramatically after TMZ treatment, we were led to speculate that MGMT promoter hypermethylation is ubiquitous in tumor tissues, and the factors causing hypermethylation exist in the early stage of the tumor development. This evidence concerns the gene MGMT and neoplasm.